Fingolimod: lessons learned and new opportunities for treating multiple sclerosis and other disorders
Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration–approved oral
therapy for relapsing forms of multiple sclerosis (MS). Research on modified fungal …
therapy for relapsing forms of multiple sclerosis (MS). Research on modified fungal …
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.
J Chun, Y Kihara, D Jonnalagadda… - Annual Review of …, 2019 - europepmc.org
Abstract Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration–
approved oral therapy for relapsing forms of multiple sclerosis (MS). Research on modified …
approved oral therapy for relapsing forms of multiple sclerosis (MS). Research on modified …
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders
J Chun, Y Kihara… - Annual review of …, 2019 - pubmed.ncbi.nlm.nih.gov
Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration-approved oral
therapy for relapsing forms of multiple sclerosis (MS). Research on modified fungal …
therapy for relapsing forms of multiple sclerosis (MS). Research on modified fungal …
[HTML][HTML] Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders
J Chun, Y Kihara, D Jonnalagadda… - Annual review of …, 2019 - ncbi.nlm.nih.gov
Abstract Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration–
approved oral therapy for relapsing forms of multiple sclerosis (MS). Research on modified …
approved oral therapy for relapsing forms of multiple sclerosis (MS). Research on modified …
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders
J Chun, Y Kihara, D Jonnalagadda… - Annual Review of …, 2019 - cir.nii.ac.jp
抄録< jats: p> Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration–
approved oral therapy for relapsing forms of multiple sclerosis (MS). Research on modified …
approved oral therapy for relapsing forms of multiple sclerosis (MS). Research on modified …
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders
J Chun, Y Kihara… - Annual review of …, 2019 - pubmed.ncbi.nlm.nih.gov
Fingolimod (FTY720, Gilenya) was the first US Food and Drug Administration-approved oral
therapy for relapsing forms of multiple sclerosis (MS). Research on modified fungal …
therapy for relapsing forms of multiple sclerosis (MS). Research on modified fungal …